WAI CHUN BIOTEC released its annual performance, with a loss attributable to shareholders of HKD 14.623 million, a year-on-year decrease of 66.93%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, WAI CHUN BIOTEC announced its annual performance for the year ending June 30, 2025, with revenue of HKD 377 million, an increase of 1.92% year-on-year; the loss attributable to the company's owners was HKD 14.623 million, a decrease of 66.93% year-on-year; the loss per share was HKD 0.0843. The announcement stated that the improvement in loss was mainly due to a significant reduction in impairment losses on non-financial assets incurred during the reporting year
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments